Literature DB >> 32273413

Antidepressants for irritable bowel syndrome.

Paul Fritsch1, Michael R Kolber2, Christina Korownyk3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32273413      PMCID: PMC7145118     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

1.  Low FODMAP diet.

Authors:  Cian Hackett; Michael R Kolber
Journal:  Can Fam Physician       Date:  2015-08       Impact factor: 3.275

2.  Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Authors:  Alexander C Ford; Brian E Lacy; Lucinda A Harris; Eamonn M M Quigley; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2019-01       Impact factor: 10.864

Review 3.  Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  Alexander C Ford; Eamonn M M Quigley; Brian E Lacy; Anthony J Lembo; Yuri A Saito; Lawrence R Schiller; Edy E Soffer; Brennan M R Spiegel; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

Review 4.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

5.  Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).

Authors:  Paul Moayyedi; Christopher N Andrews; Glenda MacQueen; Christina Korownyk; Megan Marsiglio; Lesley Graff; Brent Kvern; Adriana Lazarescu; Louis Liu; William G Paterson; Sacha Sidani; Stephen Vanner
Journal:  J Can Assoc Gastroenterol       Date:  2019-01-17

6.  Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy.

Authors:  Karoline Freeman; Brian H Willis; Hannah Fraser; Sian Taylor-Phillips; Aileen Clarke
Journal:  BMJ Open       Date:  2019-03-08       Impact factor: 2.692

7.  Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease.

Authors:  Wei Zhang; Chiew Hsia Wong; Mallory Chavannes; Tima Mohammadi; Greg Rosenfeld
Journal:  BMJ Open       Date:  2019-04-14       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.